From the University of California Los Angeles, School of Nursing, Los Angeles, CA.
Oregon Health and Science University, School of Medicine, Portland, OR.
Crit Pathw Cardiol. 2020 Dec;19(4):206-212. doi: 10.1097/HPC.0000000000000245.
Rapid reperfusion reduces infarct size and mortality for acute coronary syndrome (ACS), but efficacy is time dependent. The aim of this study was to determine if transportation factors and clinical presentation predicted prehospital delay for suspected ACS, stratified by final diagnosis (ACS vs. no ACS).
A heterogeneous sample of emergency department (ED) patients with symptoms suggestive of ACS was enrolled at 5 US sites. Accelerated failure time models were used to specify a direct relationship between delay time and variables to predict prehospital delay by final diagnosis.
Enrolled were 609 (62.5%) men and 366 (37.5%) women, predominantly white (69.1%), with a mean age of 60.32 (±14.07) years. Median delay time was 6.68 (confidence interval 1.91, 24.94) hours; only 26.2% had a prehospital delay of 2 hours or less. Patients presenting with unusual fatigue [time ratio (TR) = 1.71, P = 0.002; TR = 1.54, P = 0.003, respectively) or self-transporting to the ED experienced significantly longer prehospital delay (TR = 1.93, P < 0.001; TR = 1.71, P < 0.001, respectively). Predictors of shorter delay in patients with ACS were shoulder pain and lightheadedness (TR = 0.65, P = 0.013 and TR = 0.67, P = 0.022, respectively). Predictors of shorter delay for patients ruled out for ACS were chest pain and sweating (TR = 0.071, P = 0.025 and TR = 0.073, P = 0.032, respectively).
Patients self-transporting to the ED had prolonged prehospital delays. Encouraging the use of EMS is important for patients with possible ACS symptoms. Calling 911 can be positively framed to at-risk patients and the community as having advanced care come to them because EMS capabilities include 12-lead ECG acquisition and possibly high-sensitivity troponin assays.
急性冠状动脉综合征(ACS)的快速再灌注可降低梗死面积和死亡率,但疗效与时间有关。本研究的目的是确定转运因素和临床表现是否可预测疑似 ACS 的院前延迟,按最终诊断(ACS 与非 ACS)进行分层。
在 5 个美国地点,对急诊科(ED)出现 ACS 症状的异质患者进行了抽样。使用加速失效时间模型指定了延迟时间与预测最终诊断的院前延迟的变量之间的直接关系。
纳入了 609 名(62.5%)男性和 366 名(37.5%)女性患者,主要为白人(69.1%),平均年龄为 60.32(±14.07)岁。中位延迟时间为 6.68(置信区间 1.91,24.94)小时;只有 26.2%的患者在 2 小时内有院前延迟。表现为不寻常疲劳[时间比(TR)= 1.71,P = 0.002;TR = 1.54,P = 0.003]或自行转运至 ED 的患者经历了显著更长的院前延迟(TR = 1.93,P < 0.001;TR = 1.71,P < 0.001)。ACS 患者中,肩痛和头晕(TR = 0.65,P = 0.013 和 TR = 0.67,P = 0.022)是预测延迟时间较短的因素。排除 ACS 的患者中,胸痛和出汗(TR = 0.071,P = 0.025 和 TR = 0.073,P = 0.032)是预测延迟时间较短的因素。
自行转运至 ED 的患者院前延迟时间较长。对于可能出现 ACS 症状的患者,鼓励使用急救医疗服务(EMS)非常重要。向高危患者和社区积极宣传拨打 911 可以获得先进的护理,因为 EMS 能力包括 12 导联心电图采集和可能的高敏肌钙蛋白检测。